1. World Health Organization. Global Health Estimates 2020. WHO, Geneva; 2021.

2. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063-1072.

3. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276-2293.

4. AHA/ASA Stroke Council. Guidelines for the management of patients with transient ischemic attack. Stroke. 2019;50(12).

5. Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215-225.

6. Rakhimbaeva G.S., Mirkhaetova N.A. Clinical and neurological characteristics of patients with chronic cerebral ischemia against the background of the combined course of hypertension and atherosclerosis depending on the course stage //»Development and innovations in science», International scientific-online conference, Netherlands

7. Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD²) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366(9479):29- 36.

8. Elkind MSV. Inflammatory mechanisms of stroke. Stroke. 2010;41(10 Suppl).

9. Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478-2486.

10. Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014;13(2):178-194.